Alamar Biosciences Launches the First Multiplexed Blood-based Immunoassay for eMTBR-Tau, One of the Most Important Biomarkers in Alzheimer’s Disease Research

Alamar Biosciences, Inc. (Nasdaq: ALMR), a leader in precision proteomics dedicated to enabling the earliest detection of disease, today launched the first commercial eMTBR-Tau immunoassay, now ...

Alamar Biosciences, Inc.: Alamar Biosciences Launches the First Multiplexed Blood-based Immunoassay for eMTBR-Tau, One of the Most Important Biomarkers in Alzheimer's Disease ...

MTBR-Tau offers a non-invasive, blood-based measurement of the tau tangle burden, the core pathology associated with disease progression and cognitive decline in Alzheimer's disease Immunoassay for ...
Goldseiten

Boreal Gold Secures 100% Ownership of the High-Grade North Star Group of Properties West of Snow Lake, Manitoba

Boreal Gold Inc. is pleased to announce that it has fulfilled the terms of the option agreement with Evolve Royalties Ltd. , whereby Boreal has exercised its option to acquire a 100-per-cent interest ...
Le Lézard

Altasciences and Evidence Matters Advance AI-Driven Drug Development With Nonclinical Automation Breakthrough

Altasciences, a fully integrated early-phase drug development organization, and Evidence Matters, a pioneer in clinical trial data science, are pleased to announce a successful proof-of-concept (POC) ...